Icure Pharmaceutical Incorporation 175250.KQ Stock
Icure Pharmaceutical Incorporation Price Chart
Icure Pharmaceutical Incorporation 175250.KQ Financial and Trading Overview
Icure Pharmaceutical Incorporation stock price | 1856 KRW |
Previous Close | 3260 KRW |
Open | 3250 KRW |
Bid | 3350 KRW x 0 |
Ask | 3355 KRW x 0 |
Day's Range | 3250 - 3425 KRW |
52 Week Range | 2305 - 13083.33 KRW |
Volume | 261.18K KRW |
Avg. Volume | 826.54K KRW |
Market Cap | 21.49B KRW |
Beta (5Y Monthly) | 1.640413 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
175250.KQ Valuation Measures
Enterprise Value | 118.04B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.3627052 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.993 |
Enterprise Value/EBITDA | -5.938 |
Trading Information
Icure Pharmaceutical Incorporation Stock Price History
Beta (5Y Monthly) | 1.640413 |
52-Week Change | -66.70% |
S&P500 52-Week Change | 20.43% |
52 Week High | 13083.33 KRW |
52 Week Low | 2305 KRW |
50-Day Moving Average | 3313.1 KRW |
200-Day Moving Average | 3858.12 KRW |
175250.KQ Share Statistics
Avg. Volume (3 month) | 826.54K KRW |
Avg. Daily Volume (10-Days) | 489.6K KRW |
Shares Outstanding | 6.41M |
Float | 19.15M |
Short Ratio | N/A |
% Held by Insiders | 10.58% |
% Held by Institutions | 0.12% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | -64.25% |
Operating Margin (ttm) | -46.53% |
Gross Margin | -11.71% |
EBITDA Margin | -33.56% |
Management Effectiveness
Return on Assets (ttm) | -7.97% |
Return on Equity (ttm) | -45.85% |
Income Statement
Revenue (ttm) | 59.24B KRW |
Revenue Per Share (ttm) | 2646.84 KRW |
Quarterly Revenue Growth (yoy) | 16.30% |
Gross Profit (ttm) | -4803518780 KRW |
EBITDA | -19880544256 KRW |
Net Income Avi to Common (ttm) | -38066970624 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 25.75B KRW |
Total Cash Per Share (mrq) | 1140.17 KRW |
Total Debt (mrq) | 85.91B KRW |
Total Debt/Equity (mrq) | 111.83 KRW |
Current Ratio (mrq) | 0.575 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -10793692160 KRW |
Levered Free Cash Flow (ttm) | 8.28B KRW |
Profile of Icure Pharmaceutical Incorporation
Country | South Korea |
State | N/A |
City | Seoul |
Address | SamSung , Icure Tower |
ZIP | 06170 |
Phone | 82 2 6959 6909 |
Website | https://www.icure.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | 177 |
Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers transdermal and intradermal drug delivery systems; functional, nature-derived, derma, and customized cosmetics products; eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. It also provides body and haircare products, including naturally derived hair and body care, baby skin, and wet wipes and cleansing tissue products; and perfumes, textile perfumes, body mists, and hair and body fragrances. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Q&A For Icure Pharmaceutical Incorporation Stock
What is a current 175250.KQ stock price?
Icure Pharmaceutical Incorporation 175250.KQ stock price today per share is 1856 KRW.
How to purchase Icure Pharmaceutical Incorporation stock?
You can buy 175250.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Icure Pharmaceutical Incorporation?
The stock symbol or ticker of Icure Pharmaceutical Incorporation is 175250.KQ.
How many shares does Icure Pharmaceutical Incorporation have in circulation?
The max supply of Icure Pharmaceutical Incorporation shares is 6.41M.
What is Icure Pharmaceutical Incorporation Price to Earnings Ratio (PE Ratio)?
Icure Pharmaceutical Incorporation PE Ratio is now.
What was Icure Pharmaceutical Incorporation earnings per share over the trailing 12 months (TTM)?
Icure Pharmaceutical Incorporation EPS is 0 KRW over the trailing 12 months.
Icure Pharmaceutical Incorporation 175250.KQ included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Kosdaq Small Index KQSM | 2810.05 KRW 2.12 USD |
-0.22
|
604.06K KRW 456 USD | 2807.71 KRW 2.12 USD | 2821.95 KRW 2.13 USD | — - | 604.06K KRW 456 USD |
Kosdaq Manufacturing Index KQ12 | 2703.28 KRW 2.04 USD |
-0.24
|
450.33K KRW 340 USD | 2701.79 KRW 2.04 USD | 2724.8 KRW 2.06 USD | — - | 450.33K KRW 340 USD |
Kosdaq Pharmaceuticals Index KQ26 | 8339.47 KRW 6.29 USD |
-0.88
|
53.46K KRW 40 USD | 8336.16 KRW 6.29 USD | 8463.48 KRW 6.39 USD | — - | 53.46K KRW 40 USD |
- {{ link.label }} {{link}}